Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial

Fiona M. Thompson; David W. Porter; Shinji L. Okitsu; Nicole Westerfeld; Denise Vogel; Stephen Todryk; Ian Poulton; Simon Correa; Claire Hutchings; Tamara Berthoud; Susanna Dunachie; Laura Andrews; Jack L. Williams; Robert Sinden; Sarah C. Gilbert; Gerd Pluschke; Rinaldo Zurbriggen; Adrian V. S. Hill

Download: PDF | Citation | XML
EzReprint New & improved!

Metrics info

Average Rating (0 User Ratings)

- Currently 0/5 Stars.
See all categories
1. Insight
  - Currently 0/5 Stars.
2. Reliability
  - Currently 0/5 Stars.
3. Style
  - Currently 0/5 Stars.
Rate This Article

Rate This Article

Please follow our guidelines for rating and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:

Remarks that could be interpreted as allegations of misconduct
Unsupported assertions or statements
Inflammatory or insulting language

Compose Your Annotation

Insight

Reliability

Style

Enter your comment title Enter your comment

Declare any competing interests.

No, I don't have any competing interests to declare.
Yes, I have competing interests to declare (enter below):

Ratings can include the following markup tags:

Emphasis: ''italic'' '''bold''' '''''bold italic'''''

Other: ^^^superscript^^ ~~_subscript~~

Metrics info

Average Rating (0 User Ratings)

Related Content

Share this Article info

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial

Related Articles info

Related Articles on the Web

Bookmarked in

Related Blog Posts info

Trackbacks

Rate This Article